Table 2.
TSPO binding affinity of N,N-dialkylindolylglyoxylamide derivatives I a–k, and 17–31.
![]() | ||||||
|---|---|---|---|---|---|---|
| Ia–k, 17–31 | ||||||
| Ligand | R1 | R2 | R3 | R4 | R5 | Ki (nM)a |
| 1 | 9.30 ± 0.50 | |||||
| 3 | 23.0 ± 3.0 | |||||
| 4 | 0.5–7 | |||||
| Ia b | nPr | nPr | H | H | H | 12.2 ± 1.0 |
| Ib b | nBu | nBu | H | H | H | 7.50 ± 0.70 |
| Ic b | nHex | nHex | H | H | H | 1.40 ± 0.20 |
| Id c | Et | nBu | H | H | H | 12.6 ± 1.0 |
| Ie c | Et | Bn | H | H | H | 11.0 ± 1.0 |
| If c | Me | nBu | H | H | H | 53.3 ± 4.0 |
| Ig c | Me | nPen | H | H | H | 12.1 ± 1.0 |
| 17 | Me | Bn | H | H | H | 12.0 ± 1.0 |
| Ih c | nPr | nPr | H | H | F | 2.67 ± 0.48 |
| Ii b | nPr | nPr | F | H | H | 4.28 ± 0.32 |
| Ij b | nHex | nHex | F | H | H | 0.370 ± 0.13 |
| 18 | Me | Bn | F | H | H | 1.80 ± 0.10 |
| Ik c | nPr | nPr | NO2 | H | H | 0.950 ± 0.10 |
| 19 | nPr | nPr | H | Me | H | 19.5 ± 1.5 |
| 20 | nBu | nBu | H | Me | H | 0.300 ± 0.050 |
| 21 | nHex | nHex | H | Me | H | 0.299 ± 0.050 |
| 22 | Et | nBu | H | Me | H | 60.2 ± 6.0 |
| 23 | Et | Bn | H | Me | H | 2.92 ± 0.30 |
| 24 | Me | nBu | H | Me | H | 190 ± 10 |
| 25 | Me | nPen | H | Me | H | 38.2 ± 4.0 |
| 26 | Me | Bn | H | Me | H | 20.9 ± 1.8 |
| 27 | nPr | nPr | H | Me | F | 23.7 ± 2.1 |
| 28 | nPr | nPr | F | Me | H | 19.8 ±2.0 |
| 29 | nHex | nHex | F | Me | H | 1.07±0.11 |
| 30 | Me | Bn | F | Me | H | 6.77 ± 0.50 |
| 31 | nPr | nPr | NO2 | Me | H | 5.70 ± 0.45 |
The concentration of tested compounds that inhibited [3H]1 binding to rat kidney mitochondrial membranes (IC50) by 50% was determined with six concentration of the displacers, each performed in triplicate. Ki values are the mean ± SEM of three determination.
Data taken from ref. 27.
Data taken from ref. 28.
